ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It is also developing ReWalk Restore, a soft suit exoskeleton for individuals who have suffered a stroke. ReWalk Robotics Ltd. markets and sells its products directly to third party payers, institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokne'am Illit, Israel.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Phone972-4959-0123
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$6.55 million
Profitability
Miscellaneous
Employees58
Next Earnings Date5/9/2019 (Estimated)
OptionableNot Optionable
Rewalk Robotics (NASDAQ:RWLK) Frequently Asked Questions
What is Rewalk Robotics' stock symbol?
Rewalk Robotics trades on the NASDAQ under the ticker symbol "RWLK."
How were Rewalk Robotics' earnings last quarter?
Rewalk Robotics Ltd (NASDAQ:RWLK) issued its quarterly earnings data on Friday, February, 8th. The medical device company reported ($0.10) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.14) by $0.04. The medical device company had revenue of $1.58 million for the quarter. Rewalk Robotics had a negative return on equity of 3,654.32% and a negative net margin of 331.18%. View Rewalk Robotics' Earnings History.
When is Rewalk Robotics' next earnings date?
What price target have analysts set for RWLK?
1 Wall Street analysts have issued 1-year target prices for Rewalk Robotics' shares. Their predictions range from $2.00 to $2.00. On average, they expect Rewalk Robotics' share price to reach $2.00 in the next year. This suggests a possible upside of 748.2% from the stock's current price. View Analyst Price Targets for Rewalk Robotics.
What is the consensus analysts' recommendation for Rewalk Robotics?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rewalk Robotics in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Rewalk Robotics.
Has Rewalk Robotics been receiving favorable news coverage?
Media coverage about RWLK stock has been trending somewhat positive on Tuesday, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Rewalk Robotics earned a media sentiment score of 1.4 on InfoTrie's scale. They also assigned media stories about the medical device company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.
Are investors shorting Rewalk Robotics?
Rewalk Robotics saw a drop in short interest in the month of February. As of February 28th, there was short interest totalling 2,267,279 shares, a drop of 49.2% from the February 15th total of 4,467,308 shares. Based on an average daily trading volume, of 5,949,919 shares, the days-to-cover ratio is currently 0.4 days. Approximately 3.9% of the shares of the company are sold short. View Rewalk Robotics' Current Options Chain.
Who are some of Rewalk Robotics' key competitors?
Some companies that are related to Rewalk Robotics include Protech Home Medical (PHM), Electromed (ELMD), Osprey Medical (OSP), Avacta Group (AVCT), Universal Biosensors (UBI), Resonance Health (RHT), Oventus Medical (OVN), Viveve Medical (VIVE), Surgical Innovations Group (SUN), EMvision Medical Devices (EMV), Anteo Diagnostics (ADO), Inspiration Healthcare Group (IHC), GI Dynamics (GID), Polarean Imaging (POLX) and Myomo (MYO).
What other stocks do shareholders of Rewalk Robotics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Rewalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners, L.P (CLMT), Micron Technology (MU), Two Harbors Investment (TWO), TransEnterix (TRXC), Novocure (NVCR), NVIDIA (NVDA), TG Therapeutics (TGTX) and Idera Pharmaceuticals (IDRA).
Who are Rewalk Robotics' key executives?
Rewalk Robotics' management team includes the folowing people:
- Mr. Lawrence J. Jasinski, CEO & Director (Age 62)
- Mr. Ori Gon, Chief Financial Officer (Age 38)
- Mr. Ofir Koren, GM and VP of Research, Devel. & Regulatory (Age 49)
- Ms. Miri Pariente, VP of QA & Operations (Age 42)
- Mr. Loren Wass, VP of Sales & Reimbursement
Who are Rewalk Robotics' major shareholders?
Rewalk Robotics' stock is owned by many different of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (0.39%) and Geode Capital Management LLC (0.79%). Company insiders that own Rewalk Robotics stock include Jeff Dykan, Jodi Gricci, Kevin Hershberger, Lawrence J Jasinski, Scp Vitalife Partners (Israel), Scp Vitalife Partners Ii Lp and Wayne Weisman. View Institutional Ownership Trends for Rewalk Robotics.
Which institutional investors are buying Rewalk Robotics stock?
How do I buy shares of Rewalk Robotics?
Shares of RWLK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rewalk Robotics' stock price today?
One share of RWLK stock can currently be purchased for approximately $0.2358.
How big of a company is Rewalk Robotics?
Rewalk Robotics has a market capitalization of $17.26 million and generates $6.55 million in revenue each year. The medical device company earns $-21,670,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis. Rewalk Robotics employs 58 workers across the globe.
What is Rewalk Robotics' official website?
How can I contact Rewalk Robotics?
Rewalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The medical device company can be reached via phone at 972-4959-0123 or via email at [email protected]
MarketBeat Community Rating for Rewalk Robotics (NASDAQ RWLK)
MarketBeat's community ratings are surveys of what our community members think about Rewalk Robotics and other stocks. Vote "Outperform" if you believe RWLK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RWLK will underperform the S&P 500 over the long term. You may vote once every thirty days.
